Minimally Invasive Healthcare (00853) rose more than 6% in the intraday period. As of press release, it was up 3.93% to HK$5.29, with a turnover of HK$25.4134 million.
The Zhitong Finance App learned that minimally invasive healthcare (00853) rose more than 6% in the intraday period. As of press release, it had risen 3.93% to HK$5.29, with a turnover of HK$25.4134 million.
According to the news, Minimally Invasive Healthcare announced that the net loss for the six months ending June 30, 2024 is expected to be about 0.105 billion US dollars to 0.125 billion US dollars, narrowing by about 43% to 52% year on year; adjusted net loss is expected to be about 65 million US dollars to 75 million US dollars, narrowing by about 60% to 65% year on year.
The sharp reduction in losses mainly benefited from the commercialization of the company's leading products driving a further increase in market share. New products contributed to an increase in revenue. Revenue continued to grow steadily during the period, leading to an increase in gross profit; completed the sale of several non-core businesses, and actively shut down several R&D projects that are still in the early stages.